Klaus W. Wagner is Chief Medical Officer of Inhibrx, Inc.. Currently has a direct ownership of 215,150 shares of INBX, which is worth approximately $3.45 Million. The most recent transaction as insider was on Feb 17, 2021, when has been sold 19,559 shares (Common Stock) at a price of $25.29 per share, resulting in proceeds of $494,647. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 215K
0% 3M change
0% 12M change
Total Value Held $3.45 Million

Klaus W. Wagner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2021
SELL
Open market or private sale
$494,647 $25.29 p/Share
19,559 Reduced 8.33%
215,150 Common Stock
Feb 16 2021
SELL
Open market or private sale
$3,805,448 $24.32 p/Share
156,474 Reduced 40.0%
234,709 Common Stock

Also insider at

BOLD
Boundless Bio, Inc.
KWW

Klaus W. Wagner

Chief Medical Officer
La Jolla, CA

Track Institutional and Insider Activities on INBX

Follow Inhibrx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INBX shares.

Notify only if

Insider Trading

Get notified when an Inhibrx, Inc. insider buys or sells INBX shares.

Notify only if

News

Receive news related to Inhibrx, Inc.

Track Activities on INBX